SCHEMBL14347279

SCHEMBL14347279

CC(C)(C)c1nc(=O)[nH]c2c1ccc1ncccc12

nearest known ligand 0.42

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ MAPT P10636 3/20 0.42
▸ KDM4E B2RXH2 2/20 0.42
▸ NCOA1 Q15788 2/20 0.39
▸ CYP3A4 P08684 1/20 0.39
▸ CYP1A2 P05177 1/20 0.39
▸ CYP1B1 Q16678 1/20 0.39
▸ SMN1; SMN2 Q16637 1/20 0.38
▸ ACVR1 Q04771 3/20 0.38
▸ LMNA P02545 2/20 0.38
▸ CYP19A1 P11511 3/20 0.38
▸ BMPR1B O00238 1/20 0.36
▸ RAF1 P04049 1/20 0.36
▸ BRAF P15056 1/20 0.36
▸ BMPR1A P36894 1/20 0.36
▸ ACVR1B P36896 1/20 0.36
▸ TGFBR1 P36897 1/20 0.36
▸ ACVRL1 P37023 1/20 0.36
▸ NCOA3 Q9Y6Q9 1/20 0.35
▸ MEN1 O00255 2/20 0.35
▸ KMT2A Q03164 2/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL14347292 0.81 MAPT (0.56) MAPTKDM4ECYP3A4SMN1; SMN2LMNA
SCHEMBL14374178 0.80 KDM4E (0.42) MAPTKDM4ENCOA1CYP3A4CYP1A2
SCHEMBL14347638 0.74 AHR (0.44) MAPTKDM4ELMNAMEN1KMT2A
SCHEMBL14347269 0.73 CYP1A2 (0.53) MAPTKDM4ENCOA1CYP3A4CYP1A2
SCHEMBL1982985 0.73 CYP3A4 (0.47) MAPTKDM4ENCOA1CYP3A4CYP1A2
SCHEMBL14347584 0.73 DAO (0.46) KDM4EMEN1KMT2A
SCHEMBL14347303 0.72 CDC7 (0.36) MAPTKDM4ESMN1; SMN2HTT
SCHEMBL14347262 0.72 CDC7 (0.48) KDM4ECYP3A4CYP1A2HTT
SCHEMBL14347512 0.72 MAPT (0.40) MAPTKDM4ENCOA1CYP3A4CYP1A2
SCHEMBL14347516 0.71 SMN1; SMN2 (0.50) KDM4ESMN1; SMN2LMNAMEN1KMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7312211-B2 Pryanone compounds useful as reversible inhibitors of cysteine proteases BOEHRINGER INGELHEIM PHARMACEUTICALS, INC. 2007-12-25 — — US disclosed
Send feedback